Back to Journals » Therapeutics and Clinical Risk Management » Volume 4 » Issue 1

A novel vaccine for cervical cancer: quadrivalent human papillomavirus (types 6, 11, 16 and 18) recombinant vaccine (Gardasil®)

Total article views   HTML views PDF downloads Totals
10,288 Dovepress* 10,288+ 1,849 12,137
Totals 10,288 1,849 12,137
*Since 8 February 2008
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 1 1

View citations on Google Scholar